WeVote
Log In

Bill

Bill

HF 1011

Optometrists prescribing and administering drugs limitations modified.

2025-2026 Regular Session Introduced by Patty Acomb and 32 co-sponsors

HF 1011 expands optometrist authority to prescribe and administer drugs in Minnesota, potentially improving eye care access while raising safety and professional boundary questions.

Second reading
#healthandhealthdepartment
0
WeVote Research Nonpartisan
Bill Summary · HF 1011

Legislative bill overview

HF 1011 modifies Minnesota's scope of practice regulations for optometrists, specifically expanding or clarifying their authority to prescribe and administer pharmaceutical drugs. The bill adjusts existing limitations on what medications optometrists can provide to patients during eye care treatment and related services.

Why is this important

Scope of practice laws directly affect healthcare access and cost. Expanding optometrist prescribing authority could reduce wait times for common eye medications, lower costs by reducing referrals to ophthalmologists, and increase competition in the market—but it also raises questions about the adequacy of optometric training in pharmacology compared to medical doctors.

Potential points of contention

  • Professional turf concerns: Ophthalmologists may oppose expanded optometrist authority, viewing it as encroachment on their specialty and potential revenue loss
  • Patient safety standards: Questions about whether optometrists' training sufficiently prepares them to diagnose complex conditions that require specific drug protocols or monitor for serious side effects
  • Scope clarity: The bill's language on which specific drugs or conditions fall within optometrist authority may create ambiguity in implementation and enforcement

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.